Insights from Feline Disease May Shed Light on Long COVID in Humans
New research from UC Davis explores how a severe cat disease caused by coronavirus may provide critical insights into long COVID in humans, with implications for immune recovery therapies.
Feline infectious peritonitis (FIP), caused by a coronavirus in cats, is a severe disease historically associated with high mortality. Interestingly, FIP shares many pathological features with severe COVID-19 in humans, including widespread inflammation, T cell exhaustion, and long-lasting immune dysfunction. Researchers at UC Davis have explored these parallels, uncovering potential pathways to treat long-term immune disturbances.
The study highlights that in cats, the coronavirus initially infects intestinal cells with mild effects, but in some cases—due to genetic and environmental factors—it infects immune cells, leading to systemic illness. FIP manifests mainly in two forms: wet FIP, with fluid accumulation in body cavities, and dry FIP, characterized by inflammation without fluid buildup. Both forms cause fever, multi-organ inflammation, and immune cell depletion, affecting about 2% of cats, especially young ones in shelters.
Until recent years, FIP was nearly always fatal. However, a breakthrough in 2018 involved the antiviral GS-441524, which could cure infected cats. Despite initial hurdles in approval, the drug is now accessible through compounding pharmacies in the U.S.
Long-term follow-ups indicate some recovered cats still exhibit enlarged lymph nodes and signs of ongoing immune activation, resembling the "long COVID" syndrome in humans. This suggests that even after viral clearance, immune systems may remain dysregulated.
To address persistent immune issues, scientists conducted clinical trials where cats treated with antiviral drugs received additional infusions of mesenchymal stromal cells (MSCs). Results showed that MSC therapy aided immune recovery by reducing overactive immune cells and promoting regulatory T cells, which help control inflammation. The approach was safe and showed promise in restoring immune balance, providing insights that could be relevant to human viral illnesses like COVID-19.
This research underscores the value of veterinary models in understanding complex immune responses, potentially paving the way for new treatments for long-term post-viral syndromes in humans.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Expanding Optician Roles to Reduce Eye Care Wait Times and Prevent Blindness
A groundbreaking study by Cardiff University demonstrates how empowering optometrists to manage eye conditions can reduce wait times and prevent blindness, ensuring timely eye care in the community.
Effectiveness of Wastewater Surveillance for COVID-19 Testing in Long-Term Care Facilities
A new study shows that wastewater surveillance at community treatment plants is an effective, low-cost method for early COVID-19 detection in long-term care facilities, helping to reduce healthcare costs and improve outbreak management.
Research Shows No Advantage of Dual Antiplatelet Therapy Over Aspirin Alone After Heart Bypass Surgery
A new study reveals that dual antiplatelet therapy offers no additional benefit over aspirin alone after coronary artery bypass surgery, but increases bleeding risks, leading to potential changes in treatment guidelines.